Journal article
Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy
Abstract
Importance: This study quantifies the trends in trimodality therapy use and its association with pathologic stage and overall survival of patients with rectal cancer at the population level.
Objective: To describe changes between 2006 and 2016 in the sequence and use of chemotherapy/radiation therapy (C/RT), multiagent (MA) chemotherapy, and total neoadjuvant therapy (TNT) for patients with stage 2/3 rectal cancer and identify associations with …
Authors
Kennecke HF; Bahnson HT; Lin B; O’Rourke C; Kaplan J; Pham H; Suen A; Simianu VV
Journal
JAMA Oncology, Vol. 8, No. 10, pp. 1466–1470
Publisher
American Medical Association (AMA)
Publication Date
October 1, 2022
DOI
10.1001/jamaoncol.2022.2831
ISSN
2374-2437